These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29460956)

  • 21. Ustekinumab treatment of TNF antagonist-induced paradoxical psoriasis flare in a patient with psoriatic arthritis: case report and review.
    Puig L; Morales-Múnera CE; López-Ferrer A; Geli C
    Dermatology; 2012; 225(1):14-7. PubMed ID: 22890275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paradoxical case effects of psoriasis following adalimumab therapy: A case series.
    Zangrilli A; Bavetta M; Mazzilli S; Garofalo V; Bianchi L
    Dermatol Ther; 2018 Nov; 31(6):e12729. PubMed ID: 30239070
    [No Abstract]   [Full Text] [Related]  

  • 23. Large Nosocomial Outbreak Associated with a Norwegian Scabies Index Case Undergoing TNF-α Inhibitor Treatment: Management and Control.
    Belvisi V; Orsi GB; Del Borgo C; Fabietti P; Ianari A; Albertoni F; Porcelli P; Potenza C; Mastroianni CM
    Infect Control Hosp Epidemiol; 2015 Nov; 36(11):1358-60. PubMed ID: 26288185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adalimumab-Induced Disseminated Superficial Porokeratosis.
    Guarneri C; Cannavò SP; Lentini M; Polimeni G
    Ann Pharmacother; 2011 Feb; 45(2):280-1. PubMed ID: 21304021
    [No Abstract]   [Full Text] [Related]  

  • 25. The therapeutic potential of TNF-alpha antagonists for skin psoriasis comorbidities.
    Piérard GE; Piérard-Franchimont C; Szepetiuk G; Paquet P; Quatresooz P
    Expert Opin Biol Ther; 2010 Aug; 10(8):1197-208. PubMed ID: 20560729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TNF-α in a molecularly targeted therapy of psoriasis and psoriatic arthritis.
    Wcisło-Dziadecka D; Zbiciak-Nylec M; Brzezińska-Wcisło L; Mazurek U
    Postgrad Med J; 2016 Mar; 92(1085):172-8. PubMed ID: 26719452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ACUTE RETINAL NECROSIS AFTER ADMINISTRATION OF ADALIMUMAB, A SYSTEMIC ANTITUMOR NECROSIS FACTOR ANTIBODY.
    Schechet SA; Garff K; Klima K; Campbell W; Schocket LS
    Retin Cases Brief Rep; 2018 Fall; 12(4):307-309. PubMed ID: 27997458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics.
    Papoutsaki M; Chimenti MS; Costanzo A; Talamonti M; Zangrilli A; Giunta A; Bianchi L; Chimenti S
    J Am Acad Dermatol; 2007 Aug; 57(2):269-75. PubMed ID: 17574299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients.
    Wollina U; Hansel G; Koch A; Schönlebe J; Köstler E; Haroske G
    Am J Clin Dermatol; 2008; 9(1):1-14. PubMed ID: 18092839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occurrence of a granulomatous mastitis and aseptic osteitis after anti-TNF therapy in a patient with pustular psoriasis.
    Garraud T; Barbarot S; Berthelot JM; Le Goff B
    Joint Bone Spine; 2016 Jan; 83(1):107-8. PubMed ID: 26054447
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of severe psoriasis and psoriatic arthritis with adalimumab in an HIV-positive patient.
    Lindsey SF; Weiss J; Lee ES; Romanelli P
    J Drugs Dermatol; 2014 Jul; 13(7):869-71. PubMed ID: 25007373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Biological treatment of psoriasis and psoriatic arthritis].
    Kragballe K; Deleuran B
    Ugeskr Laeger; 2008 Jun; 170(24):2148-50. PubMed ID: 18565300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reprint of "Anti-therapeutic antibodies and their clinical impact in patients treated with the TNF antagonist adalimumab".
    Cludts I; Spinelli FR; Morello F; Hockley J; Valesini G; Wadhwa M
    Cytokine; 2018 Jan; 101():70-77. PubMed ID: 29174881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adalimumab in psoriatic arthritis.
    Salvarani C; Pipitone N; Catanoso M; Chiarolanza I; Boiardi L; Caruso A; Pazzola G; Macchioni P; Di Lernia V; Albertini G
    J Rheumatol Suppl; 2012 Jul; 89():77-81. PubMed ID: 22751600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Down-titration of Adalimumab and Etanercept in Psoriatic Patients: A Multicentre Observational Study.
    Piaserico S; Gisondi P; De Simone C; Marinello E; Conti A; Amerio P; Peserico A
    Acta Derm Venereol; 2016 Feb; 96(2):251-2. PubMed ID: 26270599
    [No Abstract]   [Full Text] [Related]  

  • 36. [How I treat....psoriasis comorbidities by adalimumab (Humira) anti-TNFalpha].
    Piérard-Franchimont C; Henry F; Szepetiuk G; Piérard GE
    Rev Med Liege; 2010 Oct; 65(10):545-8. PubMed ID: 21128358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.
    Tobin AM; Kirby B
    BioDrugs; 2005; 19(1):47-57. PubMed ID: 15691217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple neurological abnormalities, including pontine hemorrhage, multiple sclerosis and aseptic meningitis, during anti-TNF-α therapy in psoriatic arthritis.
    Honda Y; Otsuka A; Egawa G; Inoue Y; Kuzuya A; Takahashi R; Miyachi Y; Kabashima K
    Eur J Dermatol; 2015; 25(5):487-8. PubMed ID: 26693636
    [No Abstract]   [Full Text] [Related]  

  • 39. Varicella zoster virus encephalitis during treatment with anti-tumor necrosis factor-alpha agent in a psoriatic arthritis patient.
    Buccoliero G; Lonero G; Romanelli C; Loperfido P; Resta F
    New Microbiol; 2010 Jul; 33(3):271-4. PubMed ID: 20954448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of methotrexate and tumor necrosis factor inhibitors in Japanese patients with active psoriatic arthritis.
    Mori Y; Kuwahara Y; Chiba S; Itoi E
    Mod Rheumatol; 2015 May; 25(3):431-4. PubMed ID: 25295919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.